openPR Logo
Press release

Drug Delivery Technology Market is Expected to Cross US$ 1600 Billion Globally by 2021

Drug Delivery Technology Market

Drug Delivery Technology Market

New York, May 06: Market Research Engine has published a new report titled as “Drug Delivery Technology Market by Route of Administration (Pulmonary (Nebulizer), Injectable (Device), Ocular (Liquid), Oral (Solid), Nasal (Drop), Topical (Solid), Implantable (Active), Transmucosal (Oral)) and by End Users (Hospital, ASC, Home Care) – Global Industry Analysis and Forecast 2016 - 2021”

How Big is the Drug Delivery Technology Market?

The Drug Delivery Technology Market is expected to exceed more than US$ 1600 Billion by 2021; Growing at a CAGR of 7.5% in the given forecast period.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/drug-delivery-technology-market

Drug delivery systems are engineered technologies for the targeted shipping and managed launch of healing dealers. Drug delivery is the strategy or procedure of administering a pharmaceutical compound to accomplish a remedial impact in people or animals. For the treatment of human infections, nasal and aspiratory courses of medication conveyance are increasing expanding significance. These courses give promising other options to parenteral medication conveyance especially for peptide and protein therapeutics. For this reason, a few medication conveyance frameworks have been detailed and are being examined for nasal and aspiratory conveyance. These incorporate cyclodextrins, prodrugs, gels, microspheres, proliposomes and liposomes.

The major driving factors of drug delivery technology market are as follows:

Technological advancements and drug innovation
Launching of the new products
Increase in the biologics market
Expanding prevalence of chronic disease

The drug delivery technology market is segmented on the lines of its route of administration, end user and regional. Based on route of administration segmentation it covers pulmonary drug delivery,ocular drug delivery,topical drug delivery,transmucosal drug delivery, oral drug delivery, injectable drug delivery,nasal drug delivery andimplantable drug delivery. Pulmonary drug delivery is further segmented into nebulizers, dry powder inhaler and metered dose inhaler. Ocular drug delivery segmentation contains ocular devices, semi solid and liquid. Under tropical drug delivery it covers transdermal, solid, semi solid and liquid. Transmucosal drug delivery segmentation covers oral and other. Based on oral drug delivery segmentation it covers liquid, solid and semi solid. Under injectable drug delivery segmentation it contains devices and formulations.

The drug delivery technology market is segmented on the lines of its nasal drug delivery like nasal gels, nasal powder, nasal spray and nasal drops. Under implantable drug delivery segmentation it covers passive implantable drug delivery and active implantable drug delivery. Based on end user segmentation it covers diagnostic centers, home care settings, ASCs/ clinics, hospitals and other end users.The drug delivery technology marketis geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for drug delivery technology and related technologies.

2) Analysis of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2021.

3) Identifications of new market opportunities and targeted promotional plans for drug delivery technology.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for Drug Delivery Technology with the reasons given for variations in the growth of the industry in certain regions.

The report mentions the detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Roche (Switzerland),Pfizer, Inc. (U.S.), Johnson & Johnson Services Inc. (U.S.), Novartis AG (Switzerland), and Bayer AG (Germany). Company profile includes details such as company summary, financial summary,business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Drug delivery technology Market has been segmented as below:

By Route of Administration Analysis

Pulmonary drug delivery

Nebulizers
Dry powder inhaler
Metered dose inhaler

Ocular drug delivery
Ocular devices
Semi solid
Liquid

Topical drug delivery
Transdermal
Solid
Semi solid
Liquid

Transmucosal drug delivery
Oral
Other

Oral drug delivery
Liquid
Solid
Semi solid

Injectable drug delivery
Devices
Formulations

Nasal drug delivery
Nasal gels
Nasal powder
Nasal spray
Nasal drops

Implantable drug delivery
Passive implantable drug delivery
Active implantable drug delivery

By End-user Analysis

Diagnostic centers
Home care settings
ASCs/ Clinics
Hospitals
Other end users

By Regional Analysis

North America
Europe
Asia-Pacific
Rest of the World

Reasons to Buy this Report:

1) Get the most up to date information available on all drug delivery technology in the market globally.
2) Identify growth segments and opportunities in the industry.
3) Report includes decision making on the basis of strong historic and forecast of drug delivery technology data.
4) Assess your competitor’s refining portfolio and its evolution.

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Delivery Technology Market is Expected to Cross US$ 1600 Billion Globally by 2021 here

News-ID: 526539 • Views:

More Releases from (MRE) Market Research Engine Reports

Healthcare Mobility Solutions Market is Expected to Reach US$ 148.00 Billion by …
Healthcare mobility solutions market is segmented on lines of its application, product and service and end user analysis. The healthcare mobility market is segmented on the lines of its application like mobile devices, mobile applications (Apps) and enterprise mobility platforms. The mobile device is further segmented as mobile computers, RFID scanners and barcode scanners. Based on the end user the market is segmented by payers, providers and patients. Under provider
Wireless Health Market is Expected to Reach US$ 112.0 Billion by 2021
The wireless health market is segmented on the lines of its technology, component, application and end user. The wireless health market is segmented on the lines of its technology like WLAN/Wi-Fi, WPAN, WiMAX and WWAN. WPAN is further segmented into zigbee, Bluetooth, ant+, ultra-wide band (UWB), z-wave, RFID, RTLS, and IPS. WWAN is segmented into 3G and 4G, GPRS, CDMA and GPS. Under component segmentation it covers software, hardware and
Healthcare Analytics And Medical Analytics Market is Expected to Cross US$ 31 Billion by 2022
Healthcare Analytics And Medical Analytics Market is Expected to Cross US$ 31 Bi …
The Global Healthcare Analytics And Medical Analytics Market is segmented on the lines of its application, delivery mode, component, end user and regional. Based on application segmentation it covers clinical, financial, predictive modeling, operational and administrative and research. Under delivery mode segmentation it classified into on premise, web hosted and cloud based. Components are classified into hardware, software and services. Based on end user segmentation it covers healthcare, payers, providers
Mobile Virtual Network Operator (MVNO) Market is Expected to Exceed US$ 74 Billi …
The mobile virtual network operator market is segmented on the lines of its operational model, industry vertical, subscriber and regional. Based on operational model segmentation it covers full MVNO, service operator MVNO and reseller MVNO. Under industry vertical segmentation the mobile virtual network operator covers telecom, roaming, retail, migrant, media, M2M, discount and business. Based on subscriber segmentation it covers business and consumer. The mobile virtual network operator market’s geographic

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug